USPTO serial 79273445
MP MILLICENT PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 24, 2021
- Examiner
- CLARKE, NANCY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MP MILLICENT PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kristen S. Ruisi
Kristen S. Ruisi Venable LLP151 West 42nd Street, 49th FloorNew York, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active chemical ingredients for use in the manufacture of pharmaceuticals for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemicals for use in the manufacture of pharmaceuticals for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for use in the manufacture of pharmaceuticals for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical additives for use in the manufacture of pharmaceuticals | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical and veterinary preparations, namely, contraceptive preparations and substances; sanitary preparations for medical purposes; sterilizing preparations; hormone replacement therapy preparations; dietetic foods adapted for medical or veterinary use; dietetic substances, namely, dietetic sugar and sugar substitutes for medical use, dietetic infusions for medical use, dietetic preparations for medical purposes, and dietetic beverages for medical purposes; food for babies; medicated supplements for foodstuffs for babies; dietary supplements for humans and animals; plasters for medical purposes; materials for dressings, namely, bandages for dressings, gauze for dressings, wadding for dressings, and transparent films for dressings; material for stopping teeth, dental wax; dietary supplements for humans and dietetic preparations adapted for medical purposes; dental preparations, namely, dental preparations for disclosing plaque and tartar on the teeth, anti-cavity dental coating preparations containing fluoride, dental varnish for use by dentists, dental compounds used in endodontic procedures, and dental abrasives; dental articles, namely, prefilled dental trays for applying dental compositions to teeth, materials for making dental impressions, materials for dental use for fillings, materials for dental crowns, materials for dental bridges, amalgams for dental purposes, dental sealants, dental resin cement, dental hemostatic paste, dental adhesives, medicated dental rinses, dental blanks, bonding and primer materials for dental purposes, and dental polish; dental veneers for use in dental restoration; anesthetics; analgesics; bone cement for surgical and orthopedic purposes; capsules for medicines, namely, capsules sold empty for pharmaceuticals; decongestant capsules; allergy capsules; medical and veterinary preparations for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, namely, enzyme preparations for medical purposes, and diagnostic preparations for medical purposes; medical and veterinary articles for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, namely, surgical implants comprised of living tissue; pharmaceuticals, namely, for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; natural remedies, namely, natural remedy preparations for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical dressings; medical coverings for dressings used to cover and treat wounds and burns; medical applicators for the treatment of wounds and burns; hygienic preparations and articles, namely, disinfectants for hygiene purposes and antiseptics; all-purpose deodorizing preparations for household, commercial and industrial use; air purifying preparations; absorbent articles for personal hygiene, namely, pants, sanitary pads and absorbents for incontinence; disinfectants; preparations for destroying vermin; fungicides; herbicides; pest control preparations, namely, insecticides and poisons for domestic and agricultural use; pest control articles, namely, freeze dried food bait for pest control purposes, and granular repellent for burrowing pests; drug delivery agents that facilitate the deferred, controlled or immediate release of active substances of pharmaceutical preparations, namely, drug delivery agents in the form of tablets, capsules, suppositories, dissolvable films, and coatings for tablets; drug delivery agents consisting of compounds that facilitate the deferred, controlled or immediate release of active substances of pharmaceutical preparations; drug delivery agents that facilitate the deferred, controlled or immediate release of active substances of pharmaceutical preparations, namely, drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals | ACTIVE | — |
| 010 | Medical apparatus and instruments for use in the prevention, monitoring and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; dental apparatus and instruments, namely, dental drills, dental drill bits, milling apparatus for dental purposes, dental root files, sprayers for cleaning the teeth and gums, oral irrigators, dental clips, bite trays, dental impression trays, prophy angles, apex locators, intra-oral dental light systems, dental picks, dental operating lamps, prosthetic instruments for dental purposes, hemostats, forceps for dental technical purposes, and teeth protectors; implant bridges for dental purposes; implant abutments for dental purposes; orthodontic machines and instruments for dental purposes; veterinary apparatus and instruments for use in the prevention, monitoring and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders in animals; artificial limbs, eyes and teeth; bracelets for medical purposes; blood testing apparatus; diagnostic apparatus for medical purposes used in the testing, monitoring and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical products, namely, intravaginal drug delivery devices for the deferred, controlled or immediate release of active substances of pharmaceutical preparations; medical products, namely, implantable subcutaneous drug delivery devices for hormone replacement therapy products; medical products, namely, intravaginal drug delivery devices for hormone replacement therapy products; intra vaginal ring for delivery of hormone replacement therapy products by a continuous release system; inhalers for medical use; hearing protection devices, namely, hearing protectors without the ability to reproduce or transmit sound; feeding aids, namely, disposable teats being pacifiers for babies and dishes adapted for feeding babies and children; pacifiers for babies; contraceptive devices, namely, condoms, intra-uterine contraceptive devices, diaphragms for contraception, and medical implants for contraceptive purposes; syringes for injections and for medical purposes; medical apparatus, namely, medical measuring apparatus, being those that can directly transmit data to a database, particularly thermometers for medical use, and pulse meters; medical apparatus for measuring respiratory rates and sleeping conditions; all parts and fittings of all the aforesaid goods | ACTIVE | — |
| 042 | Medical research services in the field of or for use in the field of the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders pharmacological research services in the field of or for use in the field of the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; scientific and technological research services relating to viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Millicent Pharma Limited
- Other trademarks owned by Millicent Pharma Limited
- Other trademarks owned by Millicent Pharma Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named MP MILLICENT PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 24, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 18, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Aug 18, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 18, 2026 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Aug 18, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 18, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 20, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 2, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 2, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 24, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 24, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 10, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 10, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 10, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 8, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 8, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 7, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 23, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 19, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 19, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 19, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 6, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 5, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 5, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 31, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 30, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 30, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 19, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 19, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 19, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 25, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 24, 2020 | ALIE | ASSIGNED TO LIE | — |
| Sep 24, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 24, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 24, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 12, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 11, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 11, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 11, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 11, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 11, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 11, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 11, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 11, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 28, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 11, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 11, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 19, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 18, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2020 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Dec 14, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 13, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 13, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 9, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 9, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |